- Categories :
- More
Newly Released Study Announces TBI Treatment
By:
Deutschmann Personal Injury & Disability Law (Lawyers)
| Published 01/03/2013
The Neurological Wellness Centre in Managua Nicaragua has released a new study in which they examined 629 patients afflicted by stroke or tbi following the off label use of Enbrel.
According to the latest reporting from PRWeb
Neurological Wellness Center laments that this off-label use of the drug Enbrel has the potential to help countless millions of people in their everyday lives yet is so seldom utilized. We call on the U.S. Food and Drug Administration to repurpose Enbrel for the treatment of Alzheimer’s disease, stroke and traumatic brain injury. We join with Terry Pratchett and hundreds of physicians worldwide in calling on the U.S. Food and Drug Administration (FDA) to immediately initiate the steps necessary to repurpose Enbrel for the treatment of Alzheimer’s disease, stroke and traumatic brain injury. This study by Dr. Edward Tobinick shows unequivocally in a clear and convincing way that perispinal Enbrel treatment can ameliorate the impairments countless millions of people experience due to stroke and traumatic brain injury.
More extensive clinical studies, and replication of results will be required for this protocol to be adopted widely, however it does offer hope for the treatment of TBI.
